WallStreetZenWallStreetZen

NASDAQ: JSPR
Jasper Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Jasper Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, JSPR annual revenue was $0.0, with N/A growth year-over-year.

JSPR revenue history

Current Revenue
$0.0
Current Earnings
-$63.5M
Current Profit Margin
0%

Be the first to know when JSPR announces revenue.

JSPR Revenue History By Year

JSPR Yearly RevenueJSPR RevenueJSPR ChangeJSPR Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Jasper Therapeutics Revenue FAQ

What was JSPR's revenue last quarter?

On Invalid Date, Jasper Therapeutics (NASDAQ: JSPR) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Jasper Therapeutics's revenue was $0.00.

What was Jasper Therapeutics's revenue in 2023?

Jasper Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Jasper Therapeutics make in a day?

Based on Jasper Therapeutics annual revenue for the past four years, JSPR makes an average of $0.00 per day.

What was Jasper Therapeutics's annual revenue growth in the past year?

As of Q4 2024, Jasper Therapeutics's revenue has grown null year over year. Jasper Therapeutics's revenue in the past year totaled $0.00.

How much does Jasper Therapeutics make in a year?

Jasper Therapeutics's revenue by year for the past four years is:
  • Jasper Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Jasper Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Jasper Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Jasper Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.